Scientific Management Team

 

John McMichael, Ph.D., President & CEO Beech Tree Labs

 

Dr. McMichael developed the world’s first live-virus fish vaccines for use in fish populations, and is an Alzheimer’s disease pioneer, having licensed 30+ patents to Elan Corp. plc, to support their Alzheimer’s initiative. He now holds more than 100 patents with twice that pending worldwide. His experience also includes:

 

Post-doctoral research associate, The Wistar Institute.

 

Professor of Biology and Health Sciences, Edinboro University in Pennsylvania.

 

General Manager for ImmunoTherapeutics, where he licensed a veterinary anti-inflammatory product to Eudomonics, Inc., which launched and continues to sell the product.

 

Vice President of Molecular Rx, Inc., a biopharmaceutical company focused on products for managing inflammatory responses.

 

Founder and President of Milkhaus Laboratory, Inc., a company now focused on botanical agents for nutraceutical use.

 

Founder and President of The Institute for Therapeutic Discovery, a not-for-profit organization focusing on the interplay between biochemistry and biophysics in the course and management of health and disease.

Dr. Jeffrey Osborn, 

University of Kentucky

 

Education

B.A. Amherst College; M.S. Michigan State Univ., 1976; Ph.D. Michigan State Univ., 1979; Postdoctoral Fellow, Cardiovascular Research Inst., Dept. of Internal Medicine, University of Iowa '79-'81

Research

Dr. Osborn's research career has focused upon sympathetic neural control of renal function, regulation of salt and water balance and interactions among these controllers of renal function in the pathophysiology of blood pressure regulation and arterial hypertension. The overall hypothesis of our research program has been that environmental factors lead to elevated renal sympathetic nerve activity and alter kidney function, genetic expression and subsequently evoke renal dysfunction, arterial hypertension, and cardiovascular disease. His most recent work examines the relationships among renal mitochondrial gene expression, inflammation, renal sympathetic nerve activity and the development of spontaneous hypertension. 

Current Professional Affiliations
1979-Present American Physiological Society
1982-Present American Heart Association - Council on Kidney in Cardiovascular Disease
1982-Present American Heart Association - Council on High Blood Pressure

Read More

John N. Gaitanis, MD.,

Tufts University

 

Pediatrics, Pediatric Neurology

Pediatric brain malformations, epilepsy

Dr. Gaitanis, a graduate of Brown Medical School, completed his neurology training at Children’s Hospital Boston. He went on to finish an epilepsy fellowship at Beth Israel Deaconess Medical Center before returning to Children’s Hospital Boston to join their epilepsy staff. While there, he co-founded the Comprehensive Brain Malformation Program, helping bridge clinical and basic science knowledge of these conditions. In 2004, Dr. Gaitanis returned to Brown Medical School and Hasbro Children’s Hospital where he served as the director of pediatric epilepsy. He aided in the development of ketogenic diet and epilepsy surgery programs at Brown, providing comprehensive epilepsy care for children in Rhode Island. He now serves as the Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children. Apart from his clinical duties, Dr. Gaitanis serves as the Chairperson of the Matthew Siravo Memorial Foundation’s Scientific Advisory Board, a non-profit organization dedicated to improving epilepsy advocacy and education. Dr. Gaitanis’ research is aimed at improving the sensitivity of EEG through digital signal processing. He has also published original articles and book chapters on status epilepticus, cortical malformations, and epilepsy in infancy and childhood.

 

Lloyd R. Saberski, M.D.,

Yale University

 

Pain Management,Anesthesiology

Dr. Saberski completed his medical training at New York Medical College 5PW in 1982. Internal Medicine and Anesthesiology Residencies followed this at the Albany Medical College, Albany, NY. Board Certification was granted in both specialties in 1985 and 1988 respectively. Subsequent completion of a Pain Management Fellowship at Albany Medical College in 1988 was followed by a one-year appointment to the Anesthesiology faculty with primary commitment to the Albany Center for Pain Management.

 

In 1989, Dr. Saberski joined the Yale faculty and the Yale Center for Pain Management. He founded the Yale University Fellowship in Pain Management served as its director from inception until 1998. In 1991 he was appointed Clinical Director and in 1997 Medical Director of the Center. In 1998, he was promoted to Associate Professor of Anesthesiology and became the first Yale faculty ever promoted to the rank of Associate Professor from achievements in the fields of Chronic Pain Management.

 

In 1999 Dr Saberski opened a private practice privileged at Yale New Haven Hospital and Hospital of St. Raphael dedicated to the diagnosis and management of chronic painful disorders. Dr. Saberski is devoted full-time to clinical care, research and teaching of pain management. He has published extensively and is author of over 200 manuscripts, textbook chapters, papers and lectures. He serves as consultant to numerous agencies, panels, organizations and lectures frequently on topics in pain management, especially "new technologies". Dr. Saberski is past editor the Editor-in-chief of The Pain Clinic.

 

Our Mission

NCM Biotech is an industry leader in the effort to utilize alternative medicine through cannabis research and development.  LEARN MORE

Get social with us!
  • Facebook Clean Grey
Our Location:

 

270 Bellevue Ave. Suite 225

Newport, RI. 02840

 

Phone (844) 458-1930